Skip to content
10-K

Annual Report

PMV PHARMACEUTICALS, INC. PMVP

0001193125-26-095014

← back to feed
Filed
Mar 6, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 3, 2026 53.33M sh
Shares Diluted FY 2025 · Dec 31, 2025 52.54M sh
Shares Diluted FY 2025 · Dec 31, 2024 51.58M sh
Shares Diluted FY 2025 · Dec 31, 2023 48.01M sh
Capex FY 2025 · Dec 31, 2025 $29K
Capex FY 2025 · Dec 31, 2024 $655K
Capex FY 2025 · Dec 31, 2023 $962K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$73.58M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$51.28M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$55.66M
Cash And Equivalents FY 2025 · Dec 31, 2025 $37.98M
Cash And Equivalents FY 2025 · Dec 31, 2024 $40.88M
Stockholders Equity FY 2025 · Dec 31, 2025 $104.71M
Stockholders Equity FY 2025 · Dec 31, 2024 $176.08M
Stockholders Equity FY 2025 · Dec 31, 2023 $225.69M
Stockholders Equity FY 2025 · Dec 31, 2022 $246.03M
Current Liabilities FY 2025 · Dec 31, 2025 $11.42M
Current Liabilities FY 2025 · Dec 31, 2024 $14.37M
Total Liabilities FY 2025 · Dec 31, 2025 $11.85M
Total Liabilities FY 2025 · Dec 31, 2024 $15.21M
Current Assets FY 2025 · Dec 31, 2025 $115.23M
Current Assets FY 2025 · Dec 31, 2024 $175.66M
Total Assets FY 2025 · Dec 31, 2025 $116.56M
Total Assets FY 2025 · Dec 31, 2024 $191.29M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.48
Eps Diluted FY 2025 · Dec 31, 2024 −$1.14
Eps Diluted FY 2025 · Dec 31, 2023 −$1.44
Eps Basic FY 2025 · Dec 31, 2025 −$1.48
Eps Basic FY 2025 · Dec 31, 2024 −$1.14
Eps Basic FY 2025 · Dec 31, 2023 −$1.44
Sga Expense FY 2025 · Dec 31, 2025 $16.33M
Sga Expense FY 2025 · Dec 31, 2024 $26.92M
Sga Expense FY 2025 · Dec 31, 2023 $24.25M
Rd Expense FY 2025 · Dec 31, 2025 $69.88M
Rd Expense FY 2025 · Dec 31, 2024 $58.53M
Rd Expense FY 2025 · Dec 31, 2023 $55.89M
Net Income FY 2025 · Dec 31, 2025 −$77.74M
Net Income FY 2025 · Dec 31, 2024 −$58.71M
Net Income FY 2025 · Dec 31, 2023 −$68.96M
Operating Income FY 2025 · Dec 31, 2025 −$86.21M
Operating Income FY 2025 · Dec 31, 2024 −$85.45M
Operating Income FY 2025 · Dec 31, 2023 −$80.13M